{"ticker": {"uuid": "f197801e-a1e4-44b6-b472-73539a5489a7", "symbol": "2257", "name": "Sirnaomics Ltd.", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Sirnaomics Ltd. Announces Poll Results: Approval of 2026 RSU and Share Option Schemes at Extraordinary General Meeting \u2013 Minichart", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxQck82RWNRcEtkZF9GRXNoaUNwTV9udlNUZ3FBeEJJTEhTdjBmanMwVFZLSl9md1dMbl91eGhHNTlqOGtZNjB6VjN0ckN4Rk9aWDI4YjhvVHFueUF5aVVFZkFrX0RsUV8zUjF0RTF2TFZrejFLQ0JOUjZsQWtwOHVSZ0RNS2ZVeHplNllBTUs5eDZyU2kxZTZuaVJaclpZSzNnbFFwQkswZFJzNU9rejBleXRjazd0NG9kNDZUVXNyVzRad3AzNFVsNUltWTZWcGlIcFhybkJTZkFjR3A2YmFXbmNqalpNekM0WnkxaE5n?oc=5", "source_name": "Minichart", "published_at": "2026-07-01T04:53:00+00:00", "published_display": "01 Jul 2026 04:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sirnaomics Secures HKD 138 Million Strategic Investment from Bloomage Biotech", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPMjV3dnhUOFlfN3FwWUlPNjl5eUgxUmV2Qkl2Z2xKSWtCZnJPR3JuRW85WXVEbFRTam9Xc1FJVWJrbDdMNFFKTmk1Rm0tSlNSZElzWXJxUVp4Nm96c24teWFXNmF0NXVJZmxTUVhOR0hnWHl1Sm5XeDZ2cjRpVEl3dTBFX1FSeURUQ2gwT1JWNTJjYnJHUjgyLWRibWZuVjN2US1ReVRLZXI5MnViclR6UUsxM0ZqWTFnR3RYRE1R?oc=5", "source_name": "BioPharma APAC", "published_at": "2025-09-09T01:39:59+00:00", "published_display": "09 Sep 2025 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sirnaomics Announces Demonstration of a Novel Mechanism of Action of Its siRNA Therapeutics for Focal Fat Reduction in Journal of Cosmetic Dermatology", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAJBVV95cUxQdFJ0Y2oxSmJRTWdLMU1tSzNzU0FTc2ZEUDItbmt4d1pZeWRSdF9mMWdvNjA0R3hjdWViNWEwdDBtRkVsZ2RiX0Jrbk5yZGlmbHJkWnpYVUg1YVlpNTkxdENqb1dQM2hqTkZFS2VfMTJjUkJUbjdSQ21IZmpGeDBhOThHMkIzenVEc2Z1NXliaGN6eG5RaXFZTDlWa1lqdVRkcUw1RmZ1ckp5VnE1Sm5RSnN5dU12RjdiOGxYRHJwMktaSDRCMzY1cFJJYnotVG13Z285dmJUd2xHZ3JGNmM3VTNFTTZnY083V0I5dWY2V3dLbDhGUGE5RFYycmtaVGd5ZVJzUHlvYjQ?oc=5", "source_name": "Macau Business", "published_at": "2024-09-19T07:00:00+00:00", "published_display": "19 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sirnaomics Announces 2023 Annual Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE9iejAzY21GdDUza3lxOC04X2laQVVCelg5bU8zcU93ZTlFbmtuNENjNHdYVEwtcWZBeVY1V3A3WFJRalFmR2NvQ19uRVV2MUplNG4yX1VvUzh1VlBMUml0NU5mbnNVclhsNkZ1VzdtWUpRclg1ckE?oc=5", "source_name": "Macau Business", "published_at": "2024-03-28T07:00:00+00:00", "published_display": "28 Mar 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sirnaomics Presents Positive Clinical Data of STP705 for Focal Fat Reduction", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNaThUejFJYzNTUnJhRFNoQmhwaWUxbE8zZzBtZ1V2OHBGUnF5bVN2amVFcWhzV3RMeHdqZE9Ubkc4UlU5MDNpcnkzRWNNRmlLWk4yN2RfOFo5TlpfY2NvM0FkV1BPLUZhTG9uMHUwX3dUcElmY3ZIMXY1VWNrOTVLNGw4c0VLeEY0WE04TGRmMjg1b25FRm5SS0c0THQwWml0N3cwdVJNNVY0YWFZdy1HXy1nb3R5dGs1OXhxTjFR?oc=5", "source_name": "BioPharma APAC", "published_at": "2023-11-02T07:00:00+00:00", "published_display": "02 Nov 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clifford Chance advises Sirnaomics on its Chapter 18A Hong Kong IPO and listing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQejllMDBfOEE0VmJGNGR0VG1fbFpoQzBDSEVOSnJvbjFmMWdYQ0J4RjJzaUdlWDhDUmxUZk90RThvOGZZOXBuTlJ1Q2FNZTVkMURIMTBqbXJpVkl3c2xIT0dWMHhKMy1BRklVM0Nld0lIQU45eG9xWndDektESmNZUExpRUFvcWlCQVJHMVp0djJYeHRhdkVidkgzb2hydWxGSHVDOUpuM0J2bUNOeDg3TjNyQk5IdGk0a0E?oc=5", "source_name": "Clifford Chance", "published_at": "2021-12-30T08:00:00+00:00", "published_display": "30 Dec 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Sirnaomics Ltd. Announces Poll Results: Approval of 2026 RSU and Share Option Schemes at Extraordinary General Meeting \u2013 Minichart", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxQck82RWNRcEtkZF9GRXNoaUNwTV9udlNUZ3FBeEJJTEhTdjBmanMwVFZLSl9md1dMbl91eGhHNTlqOGtZNjB6VjN0ckN4Rk9aWDI4YjhvVHFueUF5aVVFZkFrX0RsUV8zUjF0RTF2TFZrejFLQ0JOUjZsQWtwOHVSZ0RNS2ZVeHplNllBTUs5eDZyU2kxZTZuaVJaclpZSzNnbFFwQkswZFJzNU9rejBleXRjazd0NG9kNDZUVXNyVzRad3AzNFVsNUltWTZWcGlIcFhybkJTZkFjR3A2YmFXbmNqalpNekM0WnkxaE5n?oc=5", "source_name": "Minichart", "published_at": "2026-07-01T04:53:00+00:00", "published_display": "01 Jul 2026 04:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sirnaomics Secures HKD 138 Million Strategic Investment from Bloomage Biotech", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPMjV3dnhUOFlfN3FwWUlPNjl5eUgxUmV2Qkl2Z2xKSWtCZnJPR3JuRW85WXVEbFRTam9Xc1FJVWJrbDdMNFFKTmk1Rm0tSlNSZElzWXJxUVp4Nm96c24teWFXNmF0NXVJZmxTUVhOR0hnWHl1Sm5XeDZ2cjRpVEl3dTBFX1FSeURUQ2gwT1JWNTJjYnJHUjgyLWRibWZuVjN2US1ReVRLZXI5MnViclR6UUsxM0ZqWTFnR3RYRE1R?oc=5", "source_name": "BioPharma APAC", "published_at": "2025-09-09T01:39:59+00:00", "published_display": "09 Sep 2025 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sirnaomics Announces Demonstration of a Novel Mechanism of Action of Its siRNA Therapeutics for Focal Fat Reduction in Journal of Cosmetic Dermatology", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAJBVV95cUxQdFJ0Y2oxSmJRTWdLMU1tSzNzU0FTc2ZEUDItbmt4d1pZeWRSdF9mMWdvNjA0R3hjdWViNWEwdDBtRkVsZ2RiX0Jrbk5yZGlmbHJkWnpYVUg1YVlpNTkxdENqb1dQM2hqTkZFS2VfMTJjUkJUbjdSQ21IZmpGeDBhOThHMkIzenVEc2Z1NXliaGN6eG5RaXFZTDlWa1lqdVRkcUw1RmZ1ckp5VnE1Sm5RSnN5dU12RjdiOGxYRHJwMktaSDRCMzY1cFJJYnotVG13Z285dmJUd2xHZ3JGNmM3VTNFTTZnY083V0I5dWY2V3dLbDhGUGE5RFYycmtaVGd5ZVJzUHlvYjQ?oc=5", "source_name": "Macau Business", "published_at": "2024-09-19T07:00:00+00:00", "published_display": "19 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sirnaomics Announces 2023 Annual Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE9iejAzY21GdDUza3lxOC04X2laQVVCelg5bU8zcU93ZTlFbmtuNENjNHdYVEwtcWZBeVY1V3A3WFJRalFmR2NvQ19uRVV2MUplNG4yX1VvUzh1VlBMUml0NU5mbnNVclhsNkZ1VzdtWUpRclg1ckE?oc=5", "source_name": "Macau Business", "published_at": "2024-03-28T07:00:00+00:00", "published_display": "28 Mar 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sirnaomics Presents Positive Clinical Data of STP705 for Focal Fat Reduction", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNaThUejFJYzNTUnJhRFNoQmhwaWUxbE8zZzBtZ1V2OHBGUnF5bVN2amVFcWhzV3RMeHdqZE9Ubkc4UlU5MDNpcnkzRWNNRmlLWk4yN2RfOFo5TlpfY2NvM0FkV1BPLUZhTG9uMHUwX3dUcElmY3ZIMXY1VWNrOTVLNGw4c0VLeEY0WE04TGRmMjg1b25FRm5SS0c0THQwWml0N3cwdVJNNVY0YWFZdy1HXy1nb3R5dGs1OXhxTjFR?oc=5", "source_name": "BioPharma APAC", "published_at": "2023-11-02T07:00:00+00:00", "published_display": "02 Nov 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clifford Chance advises Sirnaomics on its Chapter 18A Hong Kong IPO and listing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQejllMDBfOEE0VmJGNGR0VG1fbFpoQzBDSEVOSnJvbjFmMWdYQ0J4RjJzaUdlWDhDUmxUZk90RThvOGZZOXBuTlJ1Q2FNZTVkMURIMTBqbXJpVkl3c2xIT0dWMHhKMy1BRklVM0Nld0lIQU45eG9xWndDektESmNZUExpRUFvcWlCQVJHMVp0djJYeHRhdkVidkgzb2hydWxGSHVDOUpuM0J2bUNOeDg3TjNyQk5IdGk0a0E?oc=5", "source_name": "Clifford Chance", "published_at": "2021-12-30T08:00:00+00:00", "published_display": "30 Dec 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 79, "total_relevant": 6, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 5, "score": 53, "total": 6, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 73, "events": [{"event": "general", "label": "Market update", "weight": 2.2, "count": 4}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 4.57, "latest_week": "2026-07-10", "one_week_move": 1.6, "four_week_move": -0.7, "twelve_week_move": -35.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.156179, "market_dynamics_buy_signal": false, "relative_strength": -41.84923, "fair_value_gap": -67.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 33.2597, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.6% over one week, -0.7% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 59, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "BioPharma APAC", "count": 2}, {"label": "Macau Business", "count": 2}, {"label": "Minichart", "count": 1}, {"label": "Clifford Chance", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 6}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 4}, {"label": "Earnings", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "73/100 classification confidence."}, {"label": "Company focus", "value": "6", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+1.6% over one week, -0.7% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Sirnaomics Ltd. Announces Poll Results: Approval of 2026 RSU and Share Option Schemes at Extraordinary General Meeting \u2013 Minichart"}], "updated_at": "2026-07-18T00:00:10.796110+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}